Results 111 to 120 of about 45,720 (293)
Globally, the prevalence of anxiety and depression has reached epidemic proportions. Food-derived protein hydrolysates and peptides delivered through dietary supplementation can avoid the negative risks associated with traditional pharmaceuticals while ...
Wenhui Li+5 more
doaj +1 more source
The mechanism of the pharmacological action of SM-3997: A new anxioselective anxiolytic agent
Hiroshi Shimizu+6 more
openalex +1 more source
Abstract Aim The aim of this study was to investigate the impact of pharmacist‐led person‐centred medicines reviews in general practices on medicines appropriateness, polypharmacy indicators (high‐risk prescribing markers), and patient‐reported outcome measures (PROMs).
Clare Kinahan+9 more
wiley +1 more source
Pharmacologic Characterization of a Novel Non-Benzodiazepine Selective Anxiolytic, DN-2327
Takeo Wada+7 more
openalex +1 more source
Effects of pentylenetetrazol on conflict behavior and interaction with anxiolytics in rats
Masaomi Miyamoto+3 more
openalex +1 more source
ABSTRACT Introduction Inpatient depression is associated with high morbidity and significant cognitive impairment. Inpatient treatment often focuses on short‐term stabilization with medication. Readmission rates are high. We examined the impact of a novel psychological intervention, activation therapy (AT, Behavioural Activation combined with Cognitive
Katie M. Douglas+9 more
wiley +1 more source
Abstract Background Medication non‐adherence is a leading cause of treatment failure in psychiatric populations. However, current studies highlight the lack of methodological guidance on medication assessments. Ecological Momentary Assessment (EMA), using smartphone‐based evaluations, shows promise for real‐time monitoring in everyday settings.
Valentine Chirokoff+8 more
wiley +1 more source
Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
Amir Garakani+5 more
doaj +1 more source